Full Text View
Tabular View
No Study Results Posted
Related Studies
Botulinum Toxin for the Treatment of Involuntary Movement Disorders
This study is currently recruiting participants.
Study NCT00001208   Information provided by National Institutes of Health Clinical Center (CC)
First Received: November 3, 1999   Last Updated: July 1, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Chorea
Drug Induced Dyskinesia
Movement Disorder
Muscular Disease
Tic Disorder
Additional conditions recognized in this trial
Disease
Dyskinesia, Drug-Induced
Dyskinesias
Movement Disorders
Muscular Diseases
Nervous System Diseases
Tic Disorders
Tics
More general conditions related to this trial
Central Nervous System Diseases
Disorders of Environmental Origin
Drug Toxicity
Mental Disorders
Mental Disorders Diagnosed in Childhood
Musculoskeletal Diseases
Neurologic Manifestations
Neuromuscular Diseases
Neurotoxicity Syndromes
Pathologic Processes
Poisoning
Signs and Symptoms
Additional drug interventions recognized in this trial
Botulinum Toxins
More general drug interventions related to this trial
Anti-Dyskinesia Agents
Central Nervous System Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services